Merel Mol

Dr. Merel Mol is a Researcher in the Department of Clinical Genetics at Erasmus MC, where she actively contributes to advancing the understanding of genetic mechanisms underlying neurodegenerative and heritable connective tissue disorders. Her research is highly collaborative, involving international consortia and multidisciplinary teams.

Her primary research interests include Frontotemporal Dementia, whole-genome and exome sequencing, protein kinase A dysfunction, and genetic variants in EFEMP1. She employs cutting-edge genomic and molecular techniques to uncover disease mechanisms and identify potential therapeutic targets.

The recent publications highlight a strong focus on the genetic basis of neurodegenerative diseases, particularly FTLD-TDP and PRKAR1B-related disorders, as well as rare connective tissue conditions. Her work bridges clinical genetics with molecular neuroscience, contributing significantly to both diagnostic and mechanistic understanding.

Dr. Mol has not been mentioned to have received any specific scientific awards in the provided text.

She collaborates extensively with leading researchers in the field, including Prof. John van Swieten and others in international consortia, though no formal advising or grant roles are detailed. Her research is disseminated through top-tier journals such as Nature Communications, Brain, and Annals of Neurology.